Articles that mention Johnson & Johnson -BoardProspects

Johnson & Johnson

0 Comments Leave a Comment

1-15 of 38 1 2 3 »
1. Mentioned In 38 Articles
2. US Judge Reduces J&J Opioid Fine After Mistaking Thousands for Millions
  
  Explore Business Standard Nov 16 2019 BoardNews
  
  John C Coffee Jr, director of the Center on Corporate Governance at Columbia Law School, said he viewed the Oklahoma case as singular. It only...
  Read Full Article
  
  Comment
  
  Mentions: Johnson & Johnson
3. Is CEO Pay Linked to Drug Prices? Curious Investors Failed Their Campaign to Find Out
  
  Explore Pharma News May 30 2019 BoardBlogs
  
  ... fueled increases in C-suite pay. Faith-based investor group ICCR had submitted proposals to AbbVie, Celgene, Johnson & Johnson, Merck & Co., Pfizer and Vertex requesting information about how price hikes feed sales goal...
  Read Full Article
  
  Comment
  
  Mentions: Investors Credit Suisse stock options
4. United States: SEC Commissioner Peirce "Airs Her Grievances" With CII
  
  Explore mondaq.com May 14 2019 BoardNews
  
  ...ry shareholder arbitration provisions in governing documents, triggered by the recent shareholder proposal to Johnson & Johnson. In that instance, the company received a shareholder proposal requesting adoption of mandat...
  Read Full Article
  
  Comment
  
  Mentions: Corporate Governance Investors SEC
5. Aspen Technology Appoints Georgia Keresty PhD, MPH to Its Board of Directors
  
  Explore businesswire.com Apr 18 2019 BoardMoves
  
  ...er who drives operational excellence and innovation. During a career that includes executive roles at Takeda, Johnson & Johnson, Bristol Myers Squibb and Novartis, Keresty has been responsible for operations in more than...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Management Independent Director
6. Axonics® Appoints Nancy L. Snyderman, MD and Jane E. Kiernan to its Board of Directors
  
  Explore businesswire.com Apr 8 2019 BoardMoves
  
  ... Healthymagination for twelve years and previously served as a Vice President for corporate communications at Johnson & Johnson. Dr. Snyderman is a board-certified Head and Neck surgeon and has had academic appointments ...
  Read Full Article
  
  Comment
  
  Mentions: Audit Committee Nasdaq Stanford University
7. SEC Remarks Before the Council of Institutional Investors
  
  Explore corpgov.law.harvard.edu Mar 6 2019 BoardNews
  
  ...have concerns about CII’s position with respect to the Johnson & Johnson shareholder proposal. As you know, a Johnson & Johnson shareholder submitted a proposal that, if approved, would have started the process to shift ...
  Read Full Article
  
  Comment
  
  Mentions: Dodd-Frank Conference Investors
8. CorMedix Inc. Appoints Alan W. Dunton, MD to Board of Directors
  
  Explore Digital Journal Mar 4 2019 BoardMoves
  
  ...ing Director of the Janssen Research Foundation, the R&D and regulatory arm of the pharmaceutical division of Johnson & Johnson. His earlier experience includes positions at Roche, Syntex, and Novartis. Dr. Dunton holds ...
  Read Full Article
  
  Comment
  
  Mentions: SEC NYSE stock options
9. Kadmon Announces Appointment of Cynthia Schwalm to Board of Directors
  
  Explore GlobeNewswire Jan 23 2019 BoardMoves
  
  ...business. From 1985 to 2003, Ms. Schwalm held multiple commercial roles, domestically and internationally, at Johnson & Johnson. Ms. Schwalm started her career in oncology and critical care nursing. Ms. Schwalm received ...
  Read Full Article
  
  Comment
  
  Mentions: National Association of Corporate Directors Investor Relations Management
10. ExThera Medical Elects Preston and Dollarhyde to its Board
  
  Explore businesswire.com Jan 7 2019 BoardMoves
  
  ...p – where we invented and brought to market transformational medical devices and materials for companies like Johnson & Johnson, Medtronic, Advanced NeuroStimulation Systems and Dexcom,” Ward continued. “With Greg’s mast...
  Read Full Article
  
  Comment
  
  Mentions: CFO NYSE Executive Chairman
11. Corporate Boards are Diversifying. The C-Suite Isn't
  
  Explore sfgate.com Jan 4 2019 BoardBlogs
  
  ...fficers found places for women on their boards but not at the top of their management teams. (Since my study, Johnson & Johnson and Cardinal Health have racially integrated their teams. Aetna is now part of CVS Health.) ...
  Read Full Article
  
  Comment
  
  Mentions: SEC Wells Fargo crisis
12. Pharma Giant GlaxoSmithKline Signs Mega Deal With Pfizer That Could Change the Face of Global Healthcare
  
  Explore Business Insider Dec 19 2018 BoardNews
  
  ...London (5 a.m EST). The companies claim they would have a joint market share that far exceeded rivals such as Johnson & Johnson, Sanofi, and Bayer. Integrating the two businesses should bring annual savings of £500m ($63...
  Read Full Article
  
  Comment
  
  Mentions: IPO Sanofi stake
13. Context Therapeutics Announces Key Additions to its Board of Directors
  
  Explore businesswire.com Dec 18 2018 BoardMoves
  
  ...d life cycle management for key brands and assets in the Immunology, Oncology and Anemia franchises. Prior to Johnson & Johnson, Ms. Anderson served as the Vice President and General Manager of Wyeth Lederle Vaccines fro...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Harvard Johnson & Johnson
14. J&J Announces $5 Billion Share Buyback Program After Report Wipes Out $50 Billion in Market Value
  
  Explore CNBC.com Dec 17 2018 BoardNews
  
  ...ing days following a scathing news report Friday claiming JJ knew its talc baby powders contained asbestos... Johnson & Johnson plans to repurchase $5 billion in shares after the company lost more than $50 billion in mar...
  Read Full Article
  
  Comment
  
  Mentions: Buyback Johnson & Johnson AMP
15. Ludwig N. Hantson Elected to Hologic Board of Directors
  
  Explore businesswire.com Nov 19 2018 BoardMoves
  
  ... in May 2010 as the President of Baxter BioScience, and previously held leadership roles with Novartis AG and Johnson & Johnson. “It is a pleasure to welcome Ludwig to our Board,” said Steve MacMillan, Hologic’s Chairman...
  Read Full Article
  
  Comment
  
  Mentions: SEC Nasdaq risk
16. Neon Therapeutics Appoints Industry Veteran Robert Bazemore to its Board of Directors
  
  Explore P&T Community Nov 7 2018 BoardMoves
  
  ...through its acquisition in July 2015. Prior to that, Mr. Bazemore held several senior leadership positions at Johnson & Johnson, including President of Janssen Biotech, where he led the successful launches of numerous pr...
  Read Full Article
  
  Comment
  
  Mentions: acquisition Nasdaq Neon Therapeutics
17. 1-15 of 38 1 2 3 »